Paolo Sammartino

Pubblicazioni

Titolo Pubblicato in Anno
Imaging of Peritoneal Surface Malignancies JOURNAL OF SURGICAL ONCOLOGY 2024
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2023
Colorectal Cancer with Peritoneal Metastases: The Impact of the Results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on Peritoneal Disease Management CANCERS 2023
10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis CANCERS 2023
Gastric Cancer (GC) with Peritoneal Metastases (PMs): An Overview of Italian PSM Oncoteam Evidence and Study Purposes CANCERS 2023
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis ANNALS OF SURGICAL ONCOLOGY 2023
Selected patients with peritoneal metastases from breast cancer may benefit from cytoreductive surgery: the results of a multicenter survey FRONTIERS IN ONCOLOGY 2022
Role of CT texture analysis for predicting peritoneal metastases in patients with gastric cancer LA RADIOLOGIA MEDICA 2022
Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis CANCERS 2022
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) ANNALS OF SURGICAL ONCOLOGY 2022
Fracture and migration in right atrium of a permanent venous central access system in a elderly patient: case report and literature review LA CLINICA TERAPEUTICA 2022
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) ANNALS OF SURGICAL ONCOLOGY 2022
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with synchronous peritoneal metastases: multicenter study of 'Italian Peritoneal Surface Malignancies Oncoteam - S.I.C.O.' ANNALS OF SURGICAL ONCOLOGY 2021
Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study BMJ OPEN 2021
Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) ANNALS OF SURGICAL ONCOLOGY 2021
Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2021
Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI) EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2021
ICG-assisted D3 lymphadenectomy in right colectomy for cancer ANNALS OF LAPAROSCOPIC AND ENDOSCOPIC SURGERY 2020
Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy used as treatment of colo-rectal carcinomatosis: a multicentric study UPDATES IN SURGERY 2020
Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma